Cargando…
Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro
Salinomycin is a polyether antiprotozoal antibiotic that is used as a food additive, particularly in poultry farming. By consuming animal products, there may be a chronic human exposure to salinomycin. Salinomycin inhibits the differentiation of preadipocytes into adipocytes. As human mesenchymal st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774322/ https://www.ncbi.nlm.nih.gov/pubmed/26998269 http://dx.doi.org/10.3892/br.2016.572 |
_version_ | 1782418901357821952 |
---|---|
author | SCHERZAD, AGMAL HACKENBERG, STEPHAN FROELICH, KATRIN RAK, KRISTEN HAGEN, RUDOLF TAEGER, JOHANNES BREGENZER, MAXIMILLIAN KLEINSASSER, NORBERT |
author_facet | SCHERZAD, AGMAL HACKENBERG, STEPHAN FROELICH, KATRIN RAK, KRISTEN HAGEN, RUDOLF TAEGER, JOHANNES BREGENZER, MAXIMILLIAN KLEINSASSER, NORBERT |
author_sort | SCHERZAD, AGMAL |
collection | PubMed |
description | Salinomycin is a polyether antiprotozoal antibiotic that is used as a food additive, particularly in poultry farming. By consuming animal products, there may be a chronic human exposure to salinomycin. Salinomycin inhibits the differentiation of preadipocytes into adipocytes. As human mesenchymal stem cells (MSC) may differentiate into different mesenchymal cells, it thus appeared worthwhile to investigate whether chronic salinomycin exposure impairs the functional properties of MSC and induces genotoxic effects. Bone marrow MSC were treated with low-dose salinomycin (100 nM) (MSC-Sal) for 4 weeks, while the medium containing salinomycin was changed every other day. Functional changes were evaluated and compared to MSC without salinomycin treatment (MSC-control). MSC-Sal and MSC-control were positive for cluster of differentiation 90 (CD90), CD73 and CD44, and negative for CD34. There were no differences observed in cell morphology or cytoskeletal structures following salinomycin exposure. The differentiation into adipocytes and osteocytes was not counteracted by salinomycin, and proliferation capability was not inhibited following salinomycin exposure. The migration of MSC-Sal was attenuated significantly as compared to the MSC-control. There were no genotoxic effects after 4 weeks of salinomycin exposure. The present study shows an altered migration capacity as a sign of functional impairment of MSC induced by chronic salinomycin exposure. Further in vitro toxicological investigations, particularly with primary human cells, are required to understand the impact of chronic salinomycin consumption on human cell systems. |
format | Online Article Text |
id | pubmed-4774322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-47743222016-03-18 Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro SCHERZAD, AGMAL HACKENBERG, STEPHAN FROELICH, KATRIN RAK, KRISTEN HAGEN, RUDOLF TAEGER, JOHANNES BREGENZER, MAXIMILLIAN KLEINSASSER, NORBERT Biomed Rep Articles Salinomycin is a polyether antiprotozoal antibiotic that is used as a food additive, particularly in poultry farming. By consuming animal products, there may be a chronic human exposure to salinomycin. Salinomycin inhibits the differentiation of preadipocytes into adipocytes. As human mesenchymal stem cells (MSC) may differentiate into different mesenchymal cells, it thus appeared worthwhile to investigate whether chronic salinomycin exposure impairs the functional properties of MSC and induces genotoxic effects. Bone marrow MSC were treated with low-dose salinomycin (100 nM) (MSC-Sal) for 4 weeks, while the medium containing salinomycin was changed every other day. Functional changes were evaluated and compared to MSC without salinomycin treatment (MSC-control). MSC-Sal and MSC-control were positive for cluster of differentiation 90 (CD90), CD73 and CD44, and negative for CD34. There were no differences observed in cell morphology or cytoskeletal structures following salinomycin exposure. The differentiation into adipocytes and osteocytes was not counteracted by salinomycin, and proliferation capability was not inhibited following salinomycin exposure. The migration of MSC-Sal was attenuated significantly as compared to the MSC-control. There were no genotoxic effects after 4 weeks of salinomycin exposure. The present study shows an altered migration capacity as a sign of functional impairment of MSC induced by chronic salinomycin exposure. Further in vitro toxicological investigations, particularly with primary human cells, are required to understand the impact of chronic salinomycin consumption on human cell systems. D.A. Spandidos 2016-03 2016-01-14 /pmc/articles/PMC4774322/ /pubmed/26998269 http://dx.doi.org/10.3892/br.2016.572 Text en Copyright: © Scherzad et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles SCHERZAD, AGMAL HACKENBERG, STEPHAN FROELICH, KATRIN RAK, KRISTEN HAGEN, RUDOLF TAEGER, JOHANNES BREGENZER, MAXIMILLIAN KLEINSASSER, NORBERT Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title | Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title_full | Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title_fullStr | Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title_full_unstemmed | Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title_short | Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro |
title_sort | chronic exposure of low dose salinomycin inhibits msc migration capability in vitro |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774322/ https://www.ncbi.nlm.nih.gov/pubmed/26998269 http://dx.doi.org/10.3892/br.2016.572 |
work_keys_str_mv | AT scherzadagmal chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT hackenbergstephan chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT froelichkatrin chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT rakkristen chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT hagenrudolf chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT taegerjohannes chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT bregenzermaximillian chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro AT kleinsassernorbert chronicexposureoflowdosesalinomycininhibitsmscmigrationcapabilityinvitro |